191 related articles for article (PubMed ID: 29655796)
1. Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS): A rapid test for enteric coating thickness and integrity of controlled release pellet formulations.
Alfarsi A; Dillon A; McSweeney S; Krüse J; Griffin B; Devine K; Sherry P; Henken S; Fitzpatrick S; Fitzpatrick D
Int J Pharm; 2018 Jun; 544(1):31-38. PubMed ID: 29655796
[TBL] [Abstract][Full Text] [Related]
2. A rapid in-process control (IPC) test to monitor the functionality of taste masking polymer coatings using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS).
Alfarsi A; O'Mahoney N; Arndt M; Kuntz T; McSweeney S; Krüse J; Skalsky B; Fitzpatrick D
Int J Pharm; 2019 Sep; 568():118559. PubMed ID: 31351177
[TBL] [Abstract][Full Text] [Related]
3. Rapid profiling of enteric coated drug delivery spheres via broadband acoustic resonance dissolution spectroscopy (BARDS).
Fitzpatrick D; Evans-Hurson R; Fu Y; Burke T; Krüse J; Vos B; McSweeney SG; Casaubieilh P; Keating JJ
Analyst; 2014 Mar; 139(5):1000-6. PubMed ID: 24443717
[TBL] [Abstract][Full Text] [Related]
4. Sounding out stability of enteric coated dosage forms using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS).
O'Mahoney N; Alfarsi A; O'Sullivan H; McSweeney S; Crean A; Fitzpatrick D
Int J Pharm; 2021 Jun; 602():120614. PubMed ID: 33887391
[TBL] [Abstract][Full Text] [Related]
5. Effect of Elevated pH on the Commercial Enteric-Coated Omeprazole Pellets Resistance: Patent Review and Multisource Generics Comparison.
Mohylyuk V; Yerkhova A; Katynska M; Sirko V; Patel K
AAPS PharmSciTech; 2021 Jun; 22(5):188. PubMed ID: 34159427
[TBL] [Abstract][Full Text] [Related]
6. The sound of tablets during coating erosion, disintegration, deaggregation and dissolution.
O'Mahoney N; Keating JJ; McSweeney S; Hill S; Lawrence S; Fitzpatrick D
Int J Pharm; 2020 Apr; 580():119216. PubMed ID: 32165222
[TBL] [Abstract][Full Text] [Related]
7. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
8. Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS): A Novel Approach To Investigate the Wettability of Pharmaceutical Powder Blends.
Peddapatla RVG; Ahmed MR; Blackshields CA; Sousa-Gallagher MJ; McSweeney S; Kruse J; Crean AM; Fitzpatrick D
Mol Pharm; 2018 Jan; 15(1):31-39. PubMed ID: 28926716
[TBL] [Abstract][Full Text] [Related]
9. In vitro stability, potency, and dissolution of duloxetine enteric-coated pellets after exposure to applesauce, apple juice, and chocolate pudding.
Wells KA; Losin WG
Clin Ther; 2008 Jul; 30(7):1300-8. PubMed ID: 18691989
[TBL] [Abstract][Full Text] [Related]
10. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
Varum FJ; Hatton GB; Freire AC; Basit AW
Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
[TBL] [Abstract][Full Text] [Related]
11. Amylopectin as a subcoating material improves the acidic resistance of enteric-coated pellets containing a freely soluble drug.
Guo HX; Heinämäki J; Yliruusi J
Int J Pharm; 2002 Mar; 235(1-2):79-86. PubMed ID: 11879742
[TBL] [Abstract][Full Text] [Related]
12. A top-down spectroscopic approach for correlating coating thickness distributions with the dissolution profiles of enterically coated pellets.
Xi W; Yilmaz H; Gao Z; Rodriguez JD; Willett DR
J Pharm Biomed Anal; 2023 Feb; 224():115176. PubMed ID: 36423497
[TBL] [Abstract][Full Text] [Related]
13. Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole.
He W; Fan LF; Du Q; Xiang B; Li CL; Bai M; Chang YZ; Cao DY
Chem Pharm Bull (Tokyo); 2009 Feb; 57(2):122-8. PubMed ID: 19182399
[TBL] [Abstract][Full Text] [Related]
14. Compression forces and amount of outer coating layer affecting the time-controlled disintegration of the compression-coated tablets prepared by direct compression with micronized ethylcellulose.
Lin KH; Lin SY; Li MJ
J Pharm Sci; 2001 Dec; 90(12):2005-9. PubMed ID: 11745759
[TBL] [Abstract][Full Text] [Related]
15. An in vitro/in vivo correlation for the disintegration and onset of drug release from enteric-coated pellets.
Ebel JP; Jay M; Beihn RM
Pharm Res; 1993 Feb; 10(2):233-8. PubMed ID: 8456070
[TBL] [Abstract][Full Text] [Related]
16. Development of an enteric coating formulation and process for tablets primarily composed of a highly water-soluble, organic acid.
Crotts G; Sheth A; Twist J; Ghebre-Sellassie I
Eur J Pharm Biopharm; 2001 Jan; 51(1):71-6. PubMed ID: 11154906
[TBL] [Abstract][Full Text] [Related]
17. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
Leopold CS; Eikeler D
J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
[TBL] [Abstract][Full Text] [Related]
18. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
Shibata H; Yoshida H; Izutsu K; Goda Y
J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
[TBL] [Abstract][Full Text] [Related]
19. Non-destructive prediction of enteric coating layer thickness and drug dissolution rate by near-infrared spectroscopy and X-ray computed tomography.
Ariyasu A; Hattori Y; Otsuka M
Int J Pharm; 2017 Jun; 525(1):282-290. PubMed ID: 28396246
[TBL] [Abstract][Full Text] [Related]
20. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F
Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
